The University of Southampton
University of Southampton Institutional Repository

Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study

Record type: Article

INTRODUCTION: Administration of beta-2 agonists decreased bone mineral density in rats. But the association between bronchodilators and fracture risk has not been studied in humans. OBJECTIVES: To examine the association between use of beta-2 agonists and risk of hip/femur fracture. METHODS: We conducted a population-based case-control study (6763 cases) in the Dutch PHARMO database. Current beta-2 agonist use was compared to never use. We adjusted for severity of the underlying respiratory disease and disease and drug history. RESULTS: A hospitalisation for asthma/COPD in the year before index date increased risk of hip/femur fracture: crude OR 2.17 (95% CI, 1.41-3.34). Patients using higher doses of beta-2 agonists had increased risk of hip/femur fracture: crude OR 1.94 (95% CI, 1.41-2.66) for daily dosages of >or=1600 microg albuterol equivalent. The excess fracture risk reduced after adjustment for disease severity (1.46; 95% CI, 1.02-2.08) and after exclusion of oral glucocorticoid users (1.31; 95% CI, 0.80-2.15). Risk of hip/femur fracture was similar between users of beta-2 agonists, inhaled glucocorticoids and anticholinergics. CONCLUSION: We found increases in the risk of hip/femur fracture in patients using higher doses of beta-2 agonists. However, the excess risk of hip/femur fracture substantially reduced after exclusion of oral glucocorticoid users and after adjustment for the underlying disease. Risk of hip/femur fracture was similar between users of beta-2 agonists, inhaled glucocorticoids and anticholinergics. The severity of the underlying disease, rather than the use of beta-2 agonists, may play an important role in the aetiology of hip/femur fractures in patients using beta-2 agonists.

Full text not available from this repository.

Citation

de Vries, Frank, Pouwels, Sander, Bracke, Madelon, Leufkens, Hubert G.M., Cooper, Cyrus, Lammers, Jan-Willem J. and van Staa, Tjeerd-Pieter (2007) Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study Pharmacoepidemiology and Drug Safety, 16, (6), pp. 612-619. (doi:10.1002/pds.1318).

More information

Published date: June 2007
Keywords: adrenergic beta-agonists, femoral fractures, anti-inflammatory agents, lung diseases obstructive, epidemiologic factors

Identifiers

Local EPrints ID: 61052
URI: http://eprints.soton.ac.uk/id/eprint/61052
ISSN: 1053-8569
PURE UUID: 8051fd9d-ac6b-45a5-bfb5-415b04ad328f

Catalogue record

Date deposited: 07 Oct 2008
Last modified: 17 Jul 2017 14:22

Export record

Altmetrics

Contributors

Author: Frank de Vries
Author: Sander Pouwels
Author: Madelon Bracke
Author: Hubert G.M. Leufkens
Author: Cyrus Cooper
Author: Jan-Willem J. Lammers
Author: Tjeerd-Pieter van Staa

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×